Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen Receptor
Boyu Zhang, Oh-Joon Kwon, Gervaise H. Henry, et al.
Molecular Cell (2016) Vol. 63, Iss. 6, pp. 976-989
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra
Gervaise H. Henry, Alicia Malewska, Diya B. Joseph, et al.
Cell Reports (2018) Vol. 25, Iss. 12, pp. 3530-3542.e5
Open Access | Times Cited: 282
The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
Renee E. Vickman, Omar E. Franco, Daniel Moline, et al.
Asian journal of urology (2019) Vol. 7, Iss. 3, pp. 191-202
Open Access | Times Cited: 131
Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications
Jens Staal, Rudi Beyaert
Cells (2018) Vol. 7, Iss. 9, pp. 122-122
Open Access | Times Cited: 87
The Hippo Pathway in Prostate Cancer
Omar Salem, Carsten Gram Hansen
Cells (2019) Vol. 8, Iss. 4, pp. 370-370
Open Access | Times Cited: 86
AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer
Guansong Zheng, Zhaojie Yan, Junrong Zou, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
Tracing the Evolution of Sex Hormones and Receptor‐Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease
Dengxiong Li, Zhipeng Wang, Qingxin Yu, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer
João D. Barros‐Silva, Douglas E. Linn, Ivana Steiner, et al.
Cell Reports (2018) Vol. 25, Iss. 12, pp. 3504-3518.e6
Open Access | Times Cited: 80
Prostate Luminal Progenitor Cells in Development and Cancer
Dingxiao Zhang, Shuhong Zhao, Xinyun Li, et al.
Trends in cancer (2018) Vol. 4, Iss. 11, pp. 769-783
Open Access | Times Cited: 76
Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?
Granville L. Lloyd, Jeffrey M. Marks, William A. Ricke
Current Urology Reports (2019) Vol. 20, Iss. 9
Open Access | Times Cited: 64
Spatially Restricted Stromal Wnt Signaling Restrains Prostate Epithelial Progenitor Growth through Direct and Indirect Mechanisms
Xing Wei, Li Zhang, Zhicheng Zhou, et al.
Cell stem cell (2019) Vol. 24, Iss. 5, pp. 753-768.e6
Open Access | Times Cited: 58
5‐Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia
Diya B. Joseph, Gervaise H. Henry, Alicia Malewska, et al.
The Journal of Pathology (2021) Vol. 256, Iss. 4, pp. 427-441
Open Access | Times Cited: 49
Epithelial–Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics
Luiz Paulo Chaves, Camila Morais Melo, Fabiano Pinto Saggioro, et al.
Genes (2021) Vol. 12, Iss. 12, pp. 1900-1900
Open Access | Times Cited: 48
On the role of sex steroids in biological functions by classical and non-classical pathways. An update
Miriam Pillerová, Veronika Borbélyová, Július Hodosy, et al.
Frontiers in Neuroendocrinology (2021) Vol. 62, pp. 100926-100926
Open Access | Times Cited: 46
Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
Abdolreza Haghpanah, Fatemeh Masjedi, Mehdi Salehipour, et al.
Prostate Cancer and Prostatic Diseases (2021) Vol. 25, Iss. 1, pp. 27-38
Open Access | Times Cited: 41
A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer
Franklyn De Silva, Jane Alcorn
Cancers (2022) Vol. 14, Iss. 12, pp. 2954-2954
Open Access | Times Cited: 37
Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3
Woo Yong Park, Gahee Song, Ja Yeon Park, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 37
Phosphodiesterase type 5 inhibitor tadalafil reduces prostatic fibrosis via MiR-3126-3p/FGF9 axis in benign prostatic hyperplasia
Tiewen Li, Yu Zhang, Zeng Zhou, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 6
Targeting phenotypic heterogeneity in benign prostatic hyperplasia
Douglas W. Strand, Daniel N. Costa, Franto Francis, et al.
Differentiation (2017) Vol. 96, pp. 49-61
Open Access | Times Cited: 59
Genetically Engineered Mouse Models of Prostate Cancer in the Postgenomic Era
Juan Martín Arriaga, Cory Abate‐Shen
Cold Spring Harbor Perspectives in Medicine (2018) Vol. 9, Iss. 2, pp. a030528-a030528
Open Access | Times Cited: 49
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
Deli Liu, Jonathan E. Shoag, Daniel Poliak, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 47
IL-6 Signaling Link between Inflammatory Tumor Microenvironment and Prostatic Tumorigenesis
C. Ene, Ilinca Nicolae, B. Geavlete, et al.
Analytical Cellular Pathology (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 28
A Novel Insight into the Immune-Related Interaction of Inflammatory Cytokines in Benign Prostatic Hyperplasia
Xiaokaiti Naiyila, Jinze Li, Yin Huang, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1821-1821
Open Access | Times Cited: 16
Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation
Chee Wai Chua, Nusrat J Epsi, Eva Leung, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 41
Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
Haozhe Zhang, Zhou Yi, Zengzhen Xing, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13521-13521
Open Access | Times Cited: 22
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity
Deyong Jia, Zhicheng Zhou, Oh‐Joon Kwon, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top